These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9099942)

  • 1. 90K (Mac-2 BP) in human milk.
    D'Ostilio N; Sabatino G; Natoli C; Ullrich A; Iacobelli S
    Clin Exp Immunol; 1996 Jun; 104(3):543-6. PubMed ID: 9099942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections.
    Fornarini B; Iacobelli S; Tinari N; Natoli C; De Martino M; Sabatino G
    Clin Exp Immunol; 1999 Jan; 115(1):91-4. PubMed ID: 9933425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection.
    Kittl EM; Hofmann J; Hartmann G; Sebesta C; Beer F; Bauer K; Huber KR
    Clin Chem Lab Med; 2000 Mar; 38(3):205-8. PubMed ID: 10905755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of circulating immunostimulatory 90K in Henoch-Schoenlein purpura.
    Pelliccia P; Natoli C; Petitti MT; Verrotti A; Chiarelli F; Iacobelli S
    J Clin Immunol; 1999 Mar; 19(2):143-7. PubMed ID: 10226889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.
    Artini M; Natoli C; Tinari N; Costanzo A; Marinelli R; Balsano C; Porcari P; Angelucci D; D'Egidio M; Levrero M; Iacobelli S
    J Hepatol; 1996 Aug; 25(2):212-7. PubMed ID: 8878784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
    Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
    Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo.
    Fornarini B; D'Ambrosio C; Natoli C; Tinari N; Silingardi V; Iacobelli S
    Blood; 2000 Nov; 96(9):3282-5. PubMed ID: 11050016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies specific for human tumor-associated antigen 90K/Mac-2 binding protein: tools to examine protein conformation and function.
    Laferté S; Loh LC; Keeler V
    J Cell Biochem; 2000 Apr; 77(4):540-59. PubMed ID: 10771511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells.
    Fusco O; Querzoli P; Nenci I; Natoli C; Brakebush C; Ullrich A; Iacobelli S
    Int J Cancer; 1998 Feb; 79(1):23-6. PubMed ID: 9495353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K.
    Becker R; Lenter MC; Vollkommer T; Boos AM; Pfaff D; Augustin HG; Christian S
    FASEB J; 2008 Aug; 22(8):3059-67. PubMed ID: 18490383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients.
    Iacovazzi PA; Notarnicola M; Caruso MG; Guerra V; Frisullo S; Altomare DF; Correale M
    Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):160-4. PubMed ID: 19686089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain.
    Koths K; Taylor E; Halenbeck R; Casipit C; Wang A
    J Biol Chem; 1993 Jul; 268(19):14245-9. PubMed ID: 8390986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
    Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
    Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].
    Zhang DS; Jiang WQ; Li S; Zhang XS; Mao H; Chen XQ; Li YH; Zhan J; Wang FH
    Ai Zheng; 2003 Aug; 22(8):870-3. PubMed ID: 12917038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression.
    Bair EL; Nagle RB; Ulmer TA; Laferté S; Bowden GT
    Prostate; 2006 Feb; 66(3):283-93. PubMed ID: 16245278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival.
    Strizzi L; Muraro R; Vianale G; Natoli C; Talone L; Catalano A; Mutti L; Tassi G; Procopio A
    J Pathol; 2002 Jun; 197(2):218-23. PubMed ID: 12015746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis.
    Correale M; Giannuzzi V; Iacovazzi PA; Valenza MA; Lanzillotta S; Abbate I; Quaranta M; Caruso ML; Elba S; Manghisi OG
    Anticancer Res; 1999; 19(4C):3469-72. PubMed ID: 10629637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 90K (Mac-2 BP) and galectins in tumor progression and metastasis.
    Grassadonia A; Tinari N; Iurisci I; Piccolo E; Cumashi A; Innominato P; D'Egidio M; Natoli C; Piantelli M; Iacobelli S
    Glycoconj J; 2002; 19(7-9):551-6. PubMed ID: 14758079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
    Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.